Paweł Krawczyk

Paweł Krawczyk is a Professor at the Laboratory for Immunology and Genetics, Faculty of Medicine, Medical University of Lublin. He holds an MD, PhD, and DSc, and is actively engaged in research and academic leadership. His work is centered on lung cancer, particularly non-small cell lung cancer (NSCLC), with a focus on molecular mechanisms, biomarkers, and treatment response.

His research interests span oncology, immunology, genetics, and molecular biology, with particular emphasis on drug resistance, gene expression, immunotherapy, and chemotherapy diagnostics. He utilizes advanced techniques in molecular profiling, liquid biopsy, and biomarker discovery to improve cancer detection and treatment personalization.

The analysis of his recent publications reveals a strong trend in exploring molecular biomarkers (e.g., EGFR, PD-L1, KRAS, TP53), mechanisms of therapy resistance, and novel diagnostic tools such as ctDNA and proteomics. His work bridges clinical oncology with translational research, aiming to enhance patient outcomes through precision medicine.

Scientific Contributions:

• 610 publications
• 10 promoted doctoral theses
• 4 patents
• 1 major research project
• 7 infrastructure developments

He has played a significant role in mentoring doctoral students and advancing research infrastructure. While specific grant details are not listed, his extensive publication and project record indicate sustained research funding and collaborative activity. He is an active member of the scientific community with identifiers in ORCID, Scopus, and Europe PMC.

His laboratory, the Laboratory for Immunology and Genetics, focuses on integrating immunological and genetic approaches to understand cancer biology and improve therapeutic strategies in lung cancer.